Table 2: Maximum NRS in univariable linear mixed-effects model.
|
|
β |
95%
CI |
P-value |
|
Gender |
1.09 |
0.17-2.01 |
0.02 |
|
Age* |
-0.04 |
-0.09-0.00 |
0.05 |
|
BMI |
0.00 |
-0.11-0.11 |
0.99 |
|
ASA |
-0.06 |
-0.83-0.72 |
0.89 |
|
Chronic
pain |
1.23 |
0.11-2.36 |
0.03 |
|
Psychological
factors |
2.58 |
1.44-4.07 |
<0.001 |
|
Smoking |
-0.39 |
-0.98-0.19 |
0.19 |
|
Alcohol |
-0.42 |
-0.85-0.02 |
0.06 |
|
Drugs |
-0.83 |
-1.90-0.24 |
0.13 |
|
Cirrhosis |
-0.19 |
-1.07-0.70 |
0.68 |
|
Chemotherapy** |
-0.28 |
-1.18-0.62 |
0.55 |
|
Surgery** |
-0.25 |
-1.07-0.57 |
0.55 |
|
Thermal
ablation** |
0.01 |
-0.83-0.84 |
0.98 |
|
Duration
anaesthesia |
-0.00 |
-0.01-0.01 |
0.98 |
|
Duration
procedure |
0.00 |
-0.01-0.01 |
0.75 |
|
Maximum
tumor diameter |
0.02 |
-0.04-0.07 |
0.56 |
|
Tumor
location |
-0.30 |
-1.07-0.47 |
0.44 |
|
Vascular
involvement |
0.03 |
-0.45-0.51 |
0.90 |
|
Number
of lesions |
0.12 |
-0.36-0.59 |
0.63 |
β: Regression Coefficient; CI: Confidence Interval.
* per calendar year;** < 1 year prior to treatment.